Quantum-Si Debuts New Headquarters in Branford, Connecticut
June 7, 2023
World-class laboratory and office space underpins the scaling of Quantum-Si’s operational and development capabilities in support of its goal to revolutionize protein sequencing. Company continues rich 10 year history in Connecticut with new facility through 2029 BRANFORD, Conn. -- Quantum-Si- Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the official debut of [...]
June 7, 2023
Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. CAMBRIDGE / EDINBURGH and ALDERLEY PARK, UK: Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s [...]
June 7, 2023
Boxborough, MA – RedShiftBioAnalytics (RedShiftBioⓇ) today announced it was launching the HaLCon Analyzer, an advanced, fit-for-purpose, liquid chromatography platform designed to provide protein titer results equivalent to traditional protein A, HPLC with a faster, easier, and more cost-effective platform method. The HaLCon Analyzer integrates seamlessly into any bioprocessing suite without disrupting existing workflows or equipment and [...]
June 7, 2023
Vizgen Intends to Aggressively Defend Pioneering MERSCOPE Technology in Europe Just as it has in the U.S. Previous 10x Judgments Versus Competitors Have No Application to Vizgen Cases CAMBRIDGE, Mass. ---Vizgen, Inc. ("Vizgen" or the "Company"), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today issued the below [...]
June 6, 2023
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the release of the enhanced xCELLigence RTCA Software Pro Version 2.8, an integrated software package for running and analyzing real-time cell analysis data. This improved version enables Agilent xCELLigence Real-Time Cell Analysis (RTCA) systems in GMP-regulated facilities. The xCELLigence RTCA Software Pro enables data integrity controls [...]
June 6, 2023
SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the commercial release of new kits for its Ionic® Purification System featuring new chemistry for nucleic acid extraction from formalin-fixed paraffin-embedded (FFPE) and tumor tissue. These products offer potential improvements in quality and yield of nucleic acid extracted from complex biological samples including those with low [...]
AI Microscopy Enables the Efficient Detection of Rare Events
June 6, 2023
Autonomous Microscopy powered by Aivia enables scientists to discover more by extracting the most relevant data from their experiments. Wetzlar, Germany – Leica Microsystems, a leader in microscopy and scientific instrumentation, has launched Autonomous Microscopy powered by Aivia. This new AI-based detection workflow for confocal microscopy automates the detection of rare events. It follows what [...]
SomaLogic Announces Chief Financial Officer Transition
June 6, 2023
Appoints Eliot M. Lurier, CPA, as Interim Chief Financial Officer Reaffirms 2023 Financial Guidance BOULDER, Colo. -- SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today announced a Chief Financial Officer transition. Eliot M. Lurier, CPA, is joining the company as Interim CFO while the Company conducts a search for a permanent CFO. Shaun [...]
Purolite Grows Bioprocessing Production Capacity with New U.S. Manufacturing Facility
June 6, 2023
Landenberg site strengthens supply to support lifesaving therapeutics for global customers St. Paul, Minn. – Ecolab Inc., the world’s water, hygiene and infection prevention company, today announced a further expansion of its Purolite business with the addition of a new biologics resin manufacturing facility in Landenberg, Pennsylvania. Construction plans for the new facility are underway [...]
CN Bio appoints Dr. Samantha Macro as Chief Financial Officer
June 6, 2023
Cambridge, UK: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced that it has appointed Dr. Samantha Macro as Chief Financial Officer. Samantha joins CEO, Dr Paul Brooks, on the executive team to guide all key commercial and strategic initiatives, drive revenue and shape CN Bio’s ongoing [...]